Globus Medical Inc. (GMED) exhibits 67.4% gross margins and 8.7% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 17.6x enterprise multiple and 4.8% implied options volatility.
Sustained 67.4% gross profitability converts into 16.3% operating margin and 8.7% ROIC, outpacing sector cost of capital.
ROIC: 8.7% // GM: 67.4%YoY revenue trajectory of +16.7% paired with 5.29% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +16.7% // FCF YLD: 5.29%Altman Z-Score of 10.74 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 10.74 // F-SCORE: 9/9Trading at 20.7x trailing P/E (17.4x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 20.7x // EV/EBITDA: 17.6xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $78.05 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 18.3% net margins.
NET MARGIN: 18.3% // D/E: 0.07x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for GMED & activate live FRED threshold breach alerts.